vs

Side-by-side financial comparison of CABOT CORP (CBT) and First Solar (FSLR). Click either name above to swap in a different company.

First Solar is the larger business by last-quarter revenue ($1.0B vs $849.0M, roughly 1.2× CABOT CORP). First Solar runs the higher net margin — 33.2% vs 8.6%, a 24.6% gap on every dollar of revenue. On growth, First Solar posted the faster year-over-year revenue change (23.6% vs -11.1%). Over the past eight quarters, First Solar's revenue compounded faster (1.7% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

First Solar, Inc. is a publicly traded American manufacturer of solar panels. First Solar uses rigid thin-film modules for its solar panels, and produces CdTe panels using cadmium telluride (CdTe) as a semiconductor. The company was founded in 1990 by inventor Harold McMaster as Solar Cells, Inc. In 1999 it was purchased by True North Partners, LLC, which rebranded it as First Solar, Inc. It provides end-of-life panel recycling at each of its manufacturing facilities.

CBT vs FSLR — Head-to-Head

Bigger by revenue
FSLR
FSLR
1.2× larger
FSLR
$1.0B
$849.0M
CBT
Growing faster (revenue YoY)
FSLR
FSLR
+34.7% gap
FSLR
23.6%
-11.1%
CBT
Higher net margin
FSLR
FSLR
24.6% more per $
FSLR
33.2%
8.6%
CBT
Faster 2-yr revenue CAGR
FSLR
FSLR
Annualised
FSLR
1.7%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CBT
CBT
FSLR
FSLR
Revenue
$849.0M
$1.0B
Net Profit
$73.0M
$346.6M
Gross Margin
24.9%
46.6%
Operating Margin
15.2%
33.1%
Net Margin
8.6%
33.2%
Revenue YoY
-11.1%
23.6%
Net Profit YoY
-21.5%
65.4%
EPS (diluted)
$1.37
$3.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
FSLR
FSLR
Q1 26
$1.0B
Q4 25
$849.0M
$1.7B
Q3 25
$899.0M
$1.6B
Q2 25
$923.0M
$1.1B
Q1 25
$936.0M
$844.6M
Q4 24
$955.0M
$1.5B
Q3 24
$1.0B
$887.7M
Q2 24
$1.0B
$1.0B
Net Profit
CBT
CBT
FSLR
FSLR
Q1 26
$346.6M
Q4 25
$73.0M
$520.9M
Q3 25
$43.0M
$455.9M
Q2 25
$101.0M
$341.9M
Q1 25
$94.0M
$209.5M
Q4 24
$93.0M
$393.1M
Q3 24
$137.0M
$313.0M
Q2 24
$109.0M
$349.4M
Gross Margin
CBT
CBT
FSLR
FSLR
Q1 26
46.6%
Q4 25
24.9%
39.5%
Q3 25
24.5%
38.3%
Q2 25
26.4%
45.6%
Q1 25
25.7%
40.8%
Q4 24
24.6%
37.5%
Q3 24
24.0%
50.2%
Q2 24
25.2%
49.4%
Operating Margin
CBT
CBT
FSLR
FSLR
Q1 26
33.1%
Q4 25
15.2%
32.6%
Q3 25
15.2%
29.2%
Q2 25
18.1%
33.0%
Q1 25
17.3%
26.2%
Q4 24
16.2%
30.2%
Q3 24
15.0%
36.3%
Q2 24
16.9%
36.9%
Net Margin
CBT
CBT
FSLR
FSLR
Q1 26
33.2%
Q4 25
8.6%
31.0%
Q3 25
4.8%
28.6%
Q2 25
10.9%
31.2%
Q1 25
10.0%
24.8%
Q4 24
9.7%
26.0%
Q3 24
13.7%
35.3%
Q2 24
10.7%
34.6%
EPS (diluted)
CBT
CBT
FSLR
FSLR
Q1 26
$3.22
Q4 25
$1.37
$4.84
Q3 25
$0.80
$4.24
Q2 25
$1.86
$3.18
Q1 25
$1.69
$1.95
Q4 24
$1.67
$3.66
Q3 24
$2.41
$2.91
Q2 24
$1.94
$3.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
FSLR
FSLR
Cash + ST InvestmentsLiquidity on hand
$230.0M
$2.4B
Total DebtLower is stronger
$425.8M
Stockholders' EquityBook value
$1.6B
$9.9B
Total Assets
$3.8B
$13.4B
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
FSLR
FSLR
Q1 26
$2.4B
Q4 25
$230.0M
$2.8B
Q3 25
$258.0M
$2.0B
Q2 25
$239.0M
$1.1B
Q1 25
$213.0M
$837.6M
Q4 24
$183.0M
$1.6B
Q3 24
$223.0M
$1.0B
Q2 24
$197.0M
$1.7B
Total Debt
CBT
CBT
FSLR
FSLR
Q1 26
$425.8M
Q4 25
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
Q3 24
$1.1B
Q2 24
Stockholders' Equity
CBT
CBT
FSLR
FSLR
Q1 26
$9.9B
Q4 25
$1.6B
$9.5B
Q3 25
$1.6B
$9.0B
Q2 25
$1.5B
$8.5B
Q1 25
$1.4B
$8.2B
Q4 24
$1.4B
$8.0B
Q3 24
$1.4B
$7.6B
Q2 24
$1.3B
$7.3B
Total Assets
CBT
CBT
FSLR
FSLR
Q1 26
$13.4B
Q4 25
$3.8B
$13.3B
Q3 25
$3.8B
$13.5B
Q2 25
$3.8B
$12.9B
Q1 25
$3.8B
$12.1B
Q4 24
$3.6B
$12.1B
Q3 24
$3.7B
$11.4B
Q2 24
$3.6B
$11.0B
Debt / Equity
CBT
CBT
FSLR
FSLR
Q1 26
0.04×
Q4 25
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
Q3 24
0.75×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
FSLR
FSLR
Operating Cash FlowLast quarter
$126.0M
$-214.9M
Free Cash FlowOCF − Capex
$57.0M
FCF MarginFCF / Revenue
6.7%
Capex IntensityCapex / Revenue
8.1%
Cash ConversionOCF / Net Profit
1.73×
-0.62×
TTM Free Cash FlowTrailing 4 quarters
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
FSLR
FSLR
Q1 26
$-214.9M
Q4 25
$126.0M
$1.2B
Q3 25
$219.0M
$1.3B
Q2 25
$249.0M
$149.6M
Q1 25
$73.0M
$-608.0M
Q4 24
$124.0M
$811.0M
Q3 24
$204.0M
$-53.7M
Q2 24
$207.0M
$193.0M
Free Cash Flow
CBT
CBT
FSLR
FSLR
Q1 26
Q4 25
$57.0M
$1.1B
Q3 25
$155.0M
$1.1B
Q2 25
$188.0M
$-138.6M
Q1 25
$1.0M
$-813.9M
Q4 24
$47.0M
$497.5M
Q3 24
$112.0M
$-487.7M
Q2 24
$155.0M
$-172.1M
FCF Margin
CBT
CBT
FSLR
FSLR
Q1 26
Q4 25
6.7%
63.6%
Q3 25
17.2%
67.1%
Q2 25
20.4%
-12.6%
Q1 25
0.1%
-96.4%
Q4 24
4.9%
32.9%
Q3 24
11.2%
-54.9%
Q2 24
15.3%
-17.0%
Capex Intensity
CBT
CBT
FSLR
FSLR
Q1 26
Q4 25
8.1%
10.2%
Q3 25
7.1%
12.8%
Q2 25
6.6%
26.3%
Q1 25
7.7%
24.4%
Q4 24
8.1%
20.7%
Q3 24
9.2%
48.9%
Q2 24
5.1%
36.1%
Cash Conversion
CBT
CBT
FSLR
FSLR
Q1 26
-0.62×
Q4 25
1.73×
2.38×
Q3 25
5.09×
2.79×
Q2 25
2.47×
0.44×
Q1 25
0.78×
-2.90×
Q4 24
1.33×
2.06×
Q3 24
1.49×
-0.17×
Q2 24
1.90×
0.55×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

FSLR
FSLR

Segment breakdown not available.

Related Comparisons